Neostigmine is a drug useful in treatment of myasthenia gravis, but it causes parasympathomimetic effects unless another drug is given first. This drug is:

Questions 72

ATI RN

ATI RN Test Bank

Drugs and the Peripheral Nervous System Questions

Question 1 of 5

Neostigmine is a drug useful in treatment of myasthenia gravis, but it causes parasympathomimetic effects unless another drug is given first. This drug is:

Correct Answer: A

Rationale: Neostigmine is an acetylcholinesterase inhibitor used to treat myasthenia gravis by increasing acetylcholine levels at the neuromuscular junction. However, it can also lead to excessive parasympathomimetic effects due to increased cholinergic activity. Atropine, the correct answer, is a muscarinic antagonist that can counteract these effects by blocking the action of excess acetylcholine on muscarinic receptors. Option B, Epinephrine, is a sympathomimetic drug that acts on adrenergic receptors, not cholinergic receptors affected in myasthenia gravis. Option C, Isoproterenol, is also a sympathomimetic drug targeting beta-adrenergic receptors, not muscarinic receptors involved in cholinergic overstimulation. Option D, Edrophonium, is another acetylcholinesterase inhibitor used for diagnosing myasthenia gravis but does not provide the anticholinergic effects needed to counteract neostigmine's parasympathomimetic effects. In an educational context, understanding the interactions between drugs targeting the peripheral nervous system is crucial for safe and effective patient care. Knowing the specific pharmacological actions of each drug and their indications can help in making informed decisions to manage drug interactions and adverse effects in clinical practice.

Question 2 of 5

The neurotransmitter agent that is normally released in the sinoatrial node of the heart in response to a blood pressure increase is

Correct Answer: A

Rationale: In this scenario, the correct answer is A) Acetylcholine. Acetylcholine is the neurotransmitter released in the sinoatrial (SA) node of the heart when there is an increase in blood pressure. This neurotransmitter acts to decrease heart rate, thereby counteracting the elevated blood pressure. The SA node is often referred to as the heart's natural pacemaker, as it initiates each heartbeat. Now, let's discuss why the other options are incorrect: B) Dopamine: Dopamine is not typically released in the sinoatrial node in response to changes in blood pressure. Dopamine is more commonly associated with functions related to reward and pleasure in the brain. C) Epinephrine: While epinephrine can impact heart rate and blood pressure, it is not the primary neurotransmitter released in the SA node in response to increased blood pressure. Epinephrine is more commonly associated with the fight-or-flight response. D) Glutamate: Glutamate is a major excitatory neurotransmitter in the central nervous system, but it is not involved in regulating heart rate in the sinoatrial node. To provide some educational context, understanding the specific neurotransmitters involved in regulating physiological processes like heart rate is crucial in the field of pharmacology and medicine. This knowledge helps healthcare professionals make informed decisions when prescribing medications that target these neurotransmitter systems to treat various cardiovascular conditions.

Question 3 of 5

Which one of the following can be blocked by atropine?

Correct Answer: D

Rationale: Atropine is a competitive antagonist of acetylcholine at muscarinic receptors, meaning it blocks the effects of acetylcholine on these receptors. In the given options, the correct answer is D) Tachycardia caused by infusion of acetylcholine. Atropine blocks the parasympathetic effects of acetylcholine, leading to an increase in heart rate (tachycardia) by inhibiting the vagus nerve. Option A) Decreased blood pressure caused by hexamethonium is incorrect because hexamethonium is a ganglionic blocker that acts on nicotinic receptors in the autonomic ganglia, not muscarinic receptors affected by atropine. Option B) Increased blood pressure caused by nicotine is incorrect because nicotine acts on nicotinic receptors, not muscarinic receptors like atropine. Option C) Increased skeletal muscle strength caused by neostigmine is incorrect because neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at neuromuscular junctions, enhancing muscle contractions, which is unrelated to atropine's mechanism of action. Understanding the effects of atropine on the peripheral nervous system is crucial in pharmacology and clinical practice. By grasping how atropine blocks certain responses mediated by acetylcholine, healthcare professionals can effectively manage conditions such as bradycardia or organophosphate poisoning. This knowledge is valuable in emergency situations and in various medical specialties, including anesthesiology and cardiology.

Question 4 of 5

When pupillary dilation-but not cycloplegia-is desired, a good choice is

Correct Answer: C

Rationale: In the context of drugs affecting the peripheral nervous system, the correct choice for pupillary dilation without cycloplegia is Phenylephrine (Option C). Phenylephrine is an alpha-1 adrenergic agonist which acts on the dilator muscle of the eye causing mydriasis (pupillary dilation) without affecting accommodation (cycloplegia). Homatropine (Option A) is a muscarinic antagonist that causes both pupillary dilation and cycloplegia, making it unsuitable for scenarios where only mydriasis is desired. Isoproterenol (Option B) is a non-selective beta-adrenergic agonist that can cause systemic side effects and is not commonly used for pupillary dilation. Pilocarpine (Option D) is a muscarinic agonist that causes miosis (pupillary constriction) and is used to treat conditions like glaucoma, making it the opposite of what is required in this scenario. Understanding the pharmacological actions of these drugs is crucial for healthcare professionals, especially ophthalmologists and optometrists, to make informed decisions regarding the selection of appropriate medications for specific desired outcomes in clinical practice. Phenylephrine's selective action on the dilator muscle of the eye makes it a preferred choice when pupillary dilation without affecting accommodation is needed.

Question 5 of 5

Propranolol is useful in all of the following except

Correct Answer: D

Rationale: Propranolol is a non-selective beta-blocker that exerts its effects by blocking beta-adrenergic receptors. The correct answer is D) Partial atrioventricular heart block because propranolol, as a non-selective beta-blocker, can exacerbate atrioventricular conduction abnormalities, making it contraindicated in patients with heart blocks. Option A) Angina: Propranolol is effective in treating angina by reducing cardiac workload through its negative inotropic and chronotropic effects. Option B) Familial tremor: Propranolol is commonly used to manage familial tremors due to its ability to suppress tremors by acting on cerebellar pathways. Option C) Hypertension: Propranolol is also indicated for hypertension due to its role in reducing cardiac output and renin release, thereby lowering blood pressure. Educationally, understanding the specific indications and contraindications of drugs like propranolol is crucial for healthcare professionals to ensure safe and effective patient care. Knowing when not to use a medication is just as important as knowing when to use it, to prevent adverse effects and complications in patients.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions